Close Menu

NEW YORK (GenomeWeb) – Quanterix has raised $46 million in Series D funding from new and existing investors.

Three new investors — Trinitas Capital, Cormorant Asset Management, and Arch Overage Fund — led the round with continued participation from existing investors Arch Venture Partners, Bain Capital Ventures, Tufts University, and Quanterix scientific founder David Walt. Hercules Capital also participated in the round.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.